Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients

NCT02400281 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Crenolanib besylate
DRUG: Idarubicin
DRUG: Cytarabine
DRUG: Azacytidine
DRUG: Mitoxantrone
DRUG: Etoposide
DRUG: Fludarabine
DRUG: G-CSF

Sponsor

Arog Pharmaceuticals, Inc.